Bullish
BridgeBio Pharma CEO Kumar sells $5.9m in BBIO stock
BridgeBio Pharma CEO Neil Kumar sold approximately $5.9 million worth of BBIO stock on April 9 and 10, 2026, through pre-arranged trading plans. Despi...
BBIO
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (1)
Latest BBIO News
Bullish
Bearish
BridgeBio (BBIO) CEO-linked family trusts sell 80,000 shares under 10b5-1 plan
Entities linked to BridgeBio Pharma, Inc. CEO Neil Kumar, specifically family trusts where he serves as co-trustee, sold 80,000 shares of BBIO common ...
Research BBIO on:
Ad Space